Takeda Pharmaceutical Co. Ltd. Recalls Batch of Anemia Therapy Rienso in Switzerland After Patient Death

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases of hypersensitivity. Amag shares were down about 5 percent at $23.75 in after-market trading on Tuesday. "The batch was only distributed to and sold in Switzerland and the recall is limited to the specific batch and specifically Switzerland," Lexington, Massachusetts-based Amag said in a regulatory filing on Tuesday. Amag and Japan-based Takeda are investigating the specific batch and gathering data on the adverse events.

Help employers find you! Check out all the jobs and post your resume.